丁香实验_LOGO
登录
提问
我要登录
|免费注册
点赞
收藏
wx-share
分享

Cardiac Drug Development: From Animal Models to Clinical Trials

互联网

286
Statistics from the American Heart Association show that the total number of arrhythmia-related mortalities is approx 500,000 of an estimated 2,000,000 US deaths per year, or nearly one-quarter of all cardiovascular-related deaths (1 ). The majority of such deaths, which have remained at a nearly constant ratio since the 1970s when cardiac drug development programs were formally being established within the pharmaceutical industry, are caused by ventricular fibrillation (VF; Fig. 1 ).
提问
扫一扫
丁香实验小程序二维码
实验小助手
丁香实验公众号二维码
扫码领资料
反馈
TOP
打开小程序